Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has issued a revised invite for its Q1 FY26 earnings conference call, originally sent on the same date with a broken Diamond Pass pre-registration link that has now been corrected. The call is scheduled for Thursday, July 31, 2025, at 4:30 PM IST, when the company will also announce its Q1 FY26 financial results. The management team, comprising Executive Chairman Dr. Arvind Lal, CEO Shankha Banerjee, and Group CFO Ved Prakash Goel, will present financial and operating performance followed by a Q&A. The revised invite includes updated domestic and international dial-in numbers for India, USA, UK, Singapore, and Hong Kong.
This is an administrative correction with no material impact on the business or stock. Investors should note July 31, 2025, as the date for Q1 FY26 results and the management call, which could trigger short-term stock movement based on the reported numbers and management commentary.